Speaker illustration

Professor Willibald Hochholzer

Juliusspital, Wurzburg (Germany)

Member of:

EAPCI

Willibald Hochholzer started his career at the Heart Center in Bad Krozingen, where he initiated multiple studies focusing on pharmacodynamic response to antiplatelet strategies. Thereafter, he worked at the University Basel, Switzerland, on troponin based diagnosis algorithms for myocardial infarction that has become a key recommendation of current ESC guidelines. In 2009, he was invited for a Postdoc at the TIMI Study Group of Prof. Braunwald, Harvard Medical School, Boston, where he was working on several large randomized trials. After his return to the University Heart Center in Bad Krozingen, Germany, he became Associate Professor, head of clinical research and the interventional coronary unit, and initiated randomized trials focusing on antiplatelet strategies that received the Andreas-Gruentzig-award of the German Cardiac Society. In 2022, he became Director of the Department of Cardiovascular Medicine at the Klinikum Würzburg Mitte, Würzburg, Germany.

The role of platelet function in acute coronary syndromes

Event: ESC Congress 2018

Topic: Revascularisation

Session type: Rapid Fire Abstracts

Thumbnail

ESC 365 is supported by

logo Novo Nordisk